Cargando…

The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice

Hepatic fibrosis represents an important event in the progression of chronic liver injury to cirrhosis, and is characterized by excessive extracellular matrix proteins aggregation. Early fibrosis can be reversed by inhibiting hepatocyte injury, inflammation, or hepatic stellate cells activation, so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ai, Yongqiang, Shi, Wei, Zuo, Xiaobin, Sun, Xiaoming, Chen, Yuanyuan, Wang, Zhilei, Li, Ruisheng, Song, Xueai, Dai, Wenzhang, Mu, Wenqing, Ding, Kaixin, Li, Zhiyong, Li, Qiang, Xiao, Xiaohe, Zhan, Xiaoyan, Bai, Zhaofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211319/ https://www.ncbi.nlm.nih.gov/pubmed/34149411 http://dx.doi.org/10.3389/fphar.2021.655531

Ejemplares similares

Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
por: Ai, Yongqiang, et al.
Publicado: (2021)

Curdione and Schisandrin C Synergistically Reverse Hepatic Fibrosis via Modulating the TGF-β Pathway and Inhibiting Oxidative Stress
por: Dai, Wenzhang, et al.
Publicado: (2021)

Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation
por: Mu, Wenqing, et al.
Publicado: (2023)

An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism
por: Gao, Yuan, et al.
Publicado: (2021)

Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation
por: Wang, Zhilei, et al.
Publicado: (2020)

The Cytosolic DNA-Sensing cGAS-STING Pathway in Liver Diseases
por: Wang, Zhilei, et al.
Publicado: (2021)

Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome
por: Wang, Zhilei, et al.
Publicado: (2019)

Author correction to ‘Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome’ [Acta Pharmaceutica Sinica B 9 (2019) 734–744]
por: Wang, Zhilei, et al.
Publicado: (2020)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
por: Wang, Zhilei, et al.
Publicado: (2022)

Simultaneous Estimation of Andrographolide and Wedelolactone in Herbal Formulations
por: Patel, M. B., et al.
Publicado: (2008)

HPLC-MS/MS-Mediated Analysis of the Pharmacokinetics, Bioavailability, and Tissue Distribution of Schisandrol B in Rats
por: Liang, Dahu, et al.
Publicado: (2021)

Schisandrol A Attenuates Myocardial Ischemia/Reperfusion-Induced Myocardial Apoptosis through Upregulation of 14-3-3θ
por: Gong, Shuaishuai, et al.
Publicado: (2021)

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
por: Li, Zhiyong, et al.
Publicado: (2021)

Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding
por: Sarwar, Sadia, et al.
Publicado: (2020)

Inhibitory effects and mechanisms of the anti-covid-19 traditional Chinese prescription, Keguan-1, on acute lung injury
por: Bai, Zhaofang, et al.
Publicado: (2022)

The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity
por: Mu, Wenqing, et al.
Publicado: (2022)

Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells
por: Nehybová, Tereza, et al.
Publicado: (2017)

The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis
por: Qiaolongbatu, Xijier, et al.
Publicado: (2023)

Schisandra chinensis essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy
por: Zhao, Jing, et al.
Publicado: (2022)

Isolation and purification of schisandrol A from the stems of Schisandra chinensis and cytotoxicity against human hepatocarcinoma cell lines
por: Zhu, Lijie, et al.
Publicado: (2015)

Schisandrol A Suppresses Catabolic Factor Expression by Blocking NF-κB Signaling in Osteoarthritis
por: Han, Seong Jae, et al.
Publicado: (2021)

Molecular Mechanism of the Regulatory Effect of Schisandrol A on the Immune Function of Mice Based on a Transcription Factor Regulatory Network
por: Xu, Guangyu, et al.
Publicado: (2021)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

UPLC-QTOF-MS-based lipidomic study of wedelolactone in acute colitis mice induced by dextran sulfate sodium
por: Gou, Yuanyuan, et al.
Publicado: (2023)

Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis
por: Luo, Wei, et al.
Publicado: (2023)

Wedelolactone-Loaded Micelles Ameliorate Doxorubicin-Induced Oxidative Injury in Podocytes by Improving Permeability and Bioavailability
por: Feng, Liang, et al.
Publicado: (2019)

Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
por: Shi, Wei, et al.
Publicado: (2020)

Palladium(II)-Catalyzed Efficient Synthesis of Wedelolactone and Evaluation as Potential Tyrosinase Inhibitor
por: Huang, Huidan, et al.
Publicado: (2019)

Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2
por: Qin, Wei, et al.
Publicado: (2023)

Schisandrol A protects AGEs-induced neuronal cells death by allosterically targeting ATP6V0d1 subunit of V-ATPase
por: Zhou, Xiaoqing, et al.
Publicado: (2022)

Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer
por: Chen, Huiming, et al.
Publicado: (2015)

Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling Pathway
por: Yang, Jin-yu, et al.
Publicado: (2019)

Echinatin effectively protects against NLRP3 inflammasome–driven diseases by targeting HSP90
por: Xu, Guang, et al.
Publicado: (2021)

The potential role of herbal extract Wedelolactone for treating particle-induced osteolysis: an in vivo study
por: Lu, Yung-Chang, et al.
Publicado: (2022)

Exploring the Multitarget Activity of Wedelolactone against Alzheimer’s Disease: Insights from In Silico Study
por: Du, Dang Xuan, et al.
Publicado: (2023)

Wedelolactone facilitates the early development of parthenogenetically activated porcine embryos by reducing oxidative stress and inhibiting autophagy
por: Wang, Xin-Qin, et al.
Publicado: (2022)

Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity
por: Gao, Yuan, et al.
Publicado: (2021)

Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway
por: Liu, Yan-Qiu, et al.
Publicado: (2016)

Integration of Transcriptomic and Metabolomic Data to Compare the Hepatotoxicity of Neonatal and Adult Mice Exposed to Aristolochic Acid I
por: Fang, Zhi-e, et al.
Publicado: (2022)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_857n3np9j03ah20rto7r7r0vs9